Moreover, mechanisms underlying the beneficial effects of
Results from a Duke Clinical Research Institute study that were recently
Two new but exceptionally rare Covid-19 vaccine side effects – a
The purpose of this study is to compare the effectiveness of tocilizumab (TCZ) and dexamethasone
3 million with remdesivir due to the reduction in required total ICU person days
Methods: We projected intensive care unit (ICU) needs and capacity from August 2020 to January
We determined whether early (within 48 h) dexamethasone was associated with mortality in patients hospitalised with COVID-19 not on IRS
The protective role of dexamethasone is primarily related to its anti-inflammatory properties that contain the cytokine storm related worsening of the disease
The objective of this study was to assess the effectiveness of dexamethasone and methylprednisolone in COVID-19 patients and to compare both drugs in regard to partial pressure arterial oxygen and fraction of inspired oxygen (PaO 2 /FiO 2 [P/F]) ratio improvement
2 (95%CI 13
Patients with COVID-19 who are receiving dexamethasone or another corticosteroid for an underlying condition should continue this therapy as directed by their health care provider
Evaluation of COVID-19 Therapy) study, first large clinical trial conducted to assess the impact of the use of dexamethasone on COVID-19 infection, was published in July 2020
In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support
This study aimed to compare the efficacy and safety of methylprednisolone and dexamethasone in the treatment of patients with severe COVID-19
The race for effective therapies of COVID-19 has started since the first days of the pandemic
doi: 10
Question Does time to clinical improvement or time to death differ among hospitalized patients treated with vs without remdesivir (alone or with corticosteroids) for coronavirus disease 2019 outside of a clinical trial?